Why Kymera Therapeutics Stock Popped This Week: Key Moves
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
Indices adjust divisors to reflect corporate actions and maintain continuity. This note covers the main reasons these changes occur.
28,369 articlesA flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
Nebius has drawn attention with bold AI capacity announcements and aggressive revenue targets. This guide breaks down...
Klarna stunned the market on Thursday with a rally following solid quarterly results. This article unpacks the driver...
Three quantum hardware players—IonQ, D-Wave, and Rigetti—are confronting a tough market reality. This article breaks ...
In the first half of 2026, here's plug power stock surged 37.6%, signaling a renewed optimism around hydrogen fuels a...
Salesforce unveiled a $50 billion buyback and a new AI metric, but traders remain wary that AI disruption could erode...
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
The 2-year Treasury yield climbs to 4.09%, tightening liquidity and weighing on Bitcoin’s breakout attempt. Here’s wh...
On a day when markets slid on inflation fears, one small-cap stock surprised investors by rocketing higher. Here’s wh...
When a founder sells a sizable stake, investors take note. This article digs into the implications of airbnb co-found...
As markets wobble in early 2026, preferred shares matter for investors seeking steady income and lower drama than gro...